Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2026-05-04 11:30:39 ET · period of report 2026-04-30 · accession 0001193125-26-203196 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-05-04 11:30 | 2026-04-30 | HRTX | Collard Craig A | CEO, Dir | M - OptEx | — | +84.8K | 757.9K | +13% | — |
| DM | 2026-05-04 11:30 | 2026-04-30 | HRTX | Collard Craig A | CEO, Dir | M - OptEx | $0.00 | -84.8K | 750.3K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-30 | M | A | 34,789 | — | 696,841 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 2 | Common | Common Stock | 2026-04-30 | M | A | 50,021 | — | 757,885 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F2) Includes 11,023 shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on April 30, 2026. |
| 3 | Derivative | Restricted Stock Units | 2026-04-30 | M | D | 34,789 | $0.00 | 382,675 | D | $0.00 · — to — | 34,789 Common Stock | (F3) The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025). (F3) The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025). |
| 4 | Derivative | Restricted Stock Units | 2026-04-30 | M | D | 50,021 | $0.00 | 750,316 | D | $0.00 · — to — | 50,021 Common Stock | (F4) On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. (F4) On January 30, 2026 (the "Date of Grant"), the Reporting Person was granted 800,337 RSUs which vest upon the following time-based vesting schedule: the RSUs vest in 16 equal quarterly installments beginning one quarter after the Date of Grant. |